Nicola J Mabjeesh

Title: Nicola J Mabjeesh: Innovator in Cancer Treatment

Introduction

Nicola J Mabjeesh is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a focus on downregulating specific protein complexes, his work aims to improve therapeutic outcomes for cancer patients.

Latest Patents

Mabjeesh holds 2 patents that focus on methods and pharmaceutical compositions for treating cancer and acute ischemia. His latest patents include agents capable of downregulating an MSF-A-dependent HIF-1alpha. These patents also describe methods for identifying agents that can prevent the formation of or dissociate the MSF-A-HIF-1alpha protein complex. Furthermore, they provide techniques for determining the prognosis of individuals with cancer by identifying the presence or absence of this protein complex.

Career Highlights

Throughout his career, Mabjeesh has worked with notable institutions, including the Medical Research Fund of Tel Aviv Sourasky Medical Center and the Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center. His experience in these organizations has allowed him to advance his research and contribute to the medical community.

Collaborations

Due to space constraints, the details of collaborations will not be included.

Conclusion

Nicola J Mabjeesh is a dedicated inventor whose work in cancer treatment has the potential to significantly impact patient care. His innovative approaches and patented technologies reflect his commitment to advancing medical science.